Patent · US Active

Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists

US7589097B2 · kind B2 · utility

12Cited by
9References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2007
Grant dateSep 15, 2009
Priority date—
Expiry dateDec 20, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The use of a compound of formula (I):wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.